Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.
Von Suskil M, Sultana KN, Elbezanti WO, Al-Odat OS, Chitren R, Tiwari AK, Challagundla KB, Srivastava SK, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK. Von Suskil M, et al. Among authors: challagundla kb. Int J Mol Sci. 2021 May 27;22(11):5707. doi: 10.3390/ijms22115707. Int J Mol Sci. 2021. PMID: 34071917 Free PMC article. Review.
Targeting IκappaB kinases for cancer therapy.
Awasthee N, Rai V, Chava S, Nallasamy P, Kunnumakkara AB, Bishayee A, Chauhan SC, Challagundla KB, Gupta SC. Awasthee N, et al. Among authors: challagundla kb. Semin Cancer Biol. 2019 Jun;56:12-24. doi: 10.1016/j.semcancer.2018.02.007. Epub 2018 Feb 24. Semin Cancer Biol. 2019. PMID: 29486318 Free PMC article. Review.
Old drugs, new uses: Drug repurposing in hematological malignancies.
Kale VP, Habib H, Chitren R, Patel M, Pramanik KC, Jonnalagadda SC, Challagundla K, Pandey MK. Kale VP, et al. Semin Cancer Biol. 2021 Jan;68:242-248. doi: 10.1016/j.semcancer.2020.03.005. Epub 2020 Mar 6. Semin Cancer Biol. 2021. PMID: 32151704 Review.
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma.
Gunda V, Pathania AS, Chava S, Prathipati P, Chaturvedi NK, Coulter DW, Pandey MK, Durden DL, Challagundla KB. Gunda V, et al. Among authors: challagundla kb. Cancers (Basel). 2020 Sep 10;12(9):2576. doi: 10.3390/cancers12092576. Cancers (Basel). 2020. PMID: 32927667 Free PMC article.
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.
Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, Gangula PR, Pandey MK, Durden DL, Byrareddy SN, Challagundla KB. Pathania AS, et al. Among authors: challagundla kb. Theranostics. 2021 Jan 1;11(2):731-753. doi: 10.7150/thno.51471. eCollection 2021. Theranostics. 2021. PMID: 33391502 Free PMC article. Review.
Past, Present, and a Glance into the Future of Multiple Myeloma Treatment.
Elbezanti WO, Challagundla KB, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK. Elbezanti WO, et al. Among authors: challagundla kb. Pharmaceuticals (Basel). 2023 Mar 8;16(3):415. doi: 10.3390/ph16030415. Pharmaceuticals (Basel). 2023. PMID: 36986514 Free PMC article. Review.
Neuroblastoma: Emerging trends in pathogenesis, diagnosis, and therapeutic targets.
Katta SS, Nagati V, Paturi ASV, Murakonda SP, Murakonda AB, Pandey MK, Gupta SC, Pasupulati AK, Challagundla KB. Katta SS, et al. Among authors: challagundla kb. J Control Release. 2023 May;357:444-459. doi: 10.1016/j.jconrel.2023.04.001. Epub 2023 Apr 19. J Control Release. 2023. PMID: 37023798
39 results